Skip to main content

Table 2 Occurrence of fibrosis via NFS, FIB-4 and APRI fibrosis scores

From: Use of noninvasive fibrosis calculators in an urban diabetes center suggests a large burden of undetected advanced liver disease

Fibrosis scoring system

Number of patients, mean score

NFS (n = 996)

 

 ≤0.675

n = 715 (71.8%), x̄ = − 1.129

 >0.675

n = 281 (28.2%), x̄ = 2.006

FIB-4 (n = 880)

 

 <1.3 (low risk)

n = 588 (66.9%), x̄ = 0.81

 1.3–2.67 (indeterminate risk)

n = 257 (29.2%), x̄ = 1.73

 >2.67 (high risk)

n = 35 (4.0%), x̄ = 7.69

APRI (n = 900)

 

 < 0.5

n = 844 (93.8%), x̄ = 0.201

 0.5 ≤ APRI ≤ 1.5

n = 50 (5.6%), x̄ = 0.719

 > 1.5

n = 6 (0.7%), x̄ = 8.225